| Pursue high-quality DOTS expansion and enhancement |
| Secure political commitment with adequate and sustained financing |
| Ensure early case detection and diagnosis through quality-assured bacteriology |
| Provide standardised treatment with supervision and patient support |
| Ensure effective drug supply and management |
| Monitor and evaluate performance and impact |
| Address TB-HIV, MDR-TB and the needs of poor and vulnerable populations |
| Scale-up collaborative TB/HIV activities |
| Scale-up prevention and management of MDR-TB |
| Address the needs of TB contacts, and poor and vulnerable populations |
| Contribute to health system strengthening based on primary healthcare |
| Help improve health policies, human resource development, financing, supplies, service delivery and information |
| Strengthen infection control in health services, other congregate settings and households |
| Upgrade laboratory networks and implement the Practical Approach to Lung Health |
| Adapt approaches from other fields and sectors, and foster action on the social determinants of health |
| Engage all care providers |
| Involve all public, voluntary, corporate and private providers through Public-Private Mix approaches |
| Promote the use of the International Standards for Tuberculosis Care |
| Empower people with TB and communities through partnership |
| Pursue advocacy, communication and social mobilisation |
| Foster community participation in TB care, prevention and health promotion |
| Promote use of the Patients' Charter for Tuberculosis Care |
| Enable and promote research |
| Conduct programme-based operational research and introduce new tools into practice |
| Advocate for and participate in research to develop new diagnostics, drugs and vaccines |
DOTS: directly observed treatment, short-course; TB: tuberculosis; MDR-TB: multidrug-resistant TB.